V
Valérie A McLin
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
Sep 9, 2026
McLin V.: SLIPS
3:46
3:57
4:12
4:34
4:51

Alex KniselyHOST
What are the features of neurocognitive involvement in children with chronic liver disease or portosystemic shunting? Where to start? That's your business.

Valérie McLinGUEST
I think this is why, together with a group of colleagues within Espigan, we found this acronym SLIPS because we wanted to convey the sense of spectrum.

Valérie McLinGUEST
My hypothesis, or our hypothesis, I should say, is that Since children are affected with their liver disease at different times in their development, the repercussions of liver disease on the brain are going to vary according to the underlying neurodevelopmental, neurocellular processes happening at that given time point.

Valérie McLinGUEST
So to answer your question, the clinical presentation can vary from So I guess there's two points at which you can assess the consequences.

Valérie McLinGUEST
At the time of liver disease, you might see in the typical little pediatric patient with biliary atresia, you may just see fine motor and gross motor changes that are ascribable to prolonged hospitalization and whatnot.
9 MINS LATER